Market Place
Sourcing Support
Quoin Pharma To Unveil Corporate Update And Q1 2026 Financials
30 Apr 2026 //
GLOBENEWSWIRE
Quoin Pharma Updates Corporate Status, Reveals 2025 Financials
26 Mar 2026 //
GLOBENEWSWIRE
Quoin Pharma To Unveil Corporate Update And 2025 Financial Result
19 Mar 2026 //
GLOBENEWSWIRE
Quoin Pharma Reveals Corporate Update & Q3 2025 Financials
06 Nov 2025 //
GLOBENEWSWIRE
Quoin Pharma To Update And Release Q3 2025 Financials On Nov 6
30 Oct 2025 //
GLOBENEWSWIRE
Quoin Pharmaceuticals Names New CFO for Commercialization
18 Aug 2025 //
GLOBENEWSWIRE
Quoin Pharma’s 4th Netherton Now Features Advocate Mandy Aldwin
12 Aug 2025 //
GLOBENEWSWIRE
Quoin Pharmaceuticals Unveils Q2 2025 Financials and Corporate
07 Aug 2025 //
GLOBENEWSWIRE
Quoin Pharmaceuticals Announces Q2 2025 Financial Results
31 Jul 2025 //
GLOBENEWSWIRE
Quoin Pharmaceuticals Updates Product Portfolio
29 Jul 2025 //
GLOBENEWSWIRE
Quoin Pharmaceuticals Releases Netherton Video Featuring Expert
26 Jun 2025 //
GLOBENEWSWIRE
Quoin Pharmaceuticals Updates on Q1 2025 Financial Results
13 May 2025 //
GLOBENEWSWIRE
Quoin Pharmaceuticals to Announce Q1 2025 Results on May 13, 2025
06 May 2025 //
GLOBENEWSWIRE
Quoin Pharmaceuticals Complies with Nasdaq Bid Price Rule
30 Apr 2025 //
GLOBENEWSWIRE
Quoin Pharma Files US Patent for Topical Formulations
25 Mar 2025 //
GLOBENEWSWIRE
Quoin Pharmaceuticals Updates on Q4 and Full-Year 2024 Finances
13 Mar 2025 //
GLOBENEWSWIRE
Quoin To Report Q4, Full-Year 2024 Results On March 13
06 Mar 2025 //
GLOBENEWSWIRE
Quoin Reports Positive ‘Whole Body’ Data From Netherton Syndrome Study
27 Feb 2025 //
GLOBENEWSWIRE
Quoin Pharma Announces $6.8 Million Public Offering Pricing
20 Dec 2024 //
GLOBENEWSWIRE
Quoin Pharma Corporate Update & Announce Q3 2024 Financial Results
07 Nov 2024 //
GLOBENEWSWIRE
Quoin Pharma Provides Update And Announces Q2 2024 Results
08 Aug 2024 //
GLOBENEWSWIRE
Quoin Pharmaceuticals to Initiate Clinical Study for Peeling Skin Syndrome
06 Aug 2024 //
GLOBENEWSWIRE
Quoin Pharmaceuticals To Announce Q2 2024 Results On August 8
01 Aug 2024 //
GLOBENEWSWIRE
Quoin Pharma Announces International Expansion of Ongoing Clinical Trials
27 Jun 2024 //
GLOBENEWSWIRE
Quoin Pharmaceuticals Signs Research Agreement With UCC Ireland
12 Jun 2024 //
GLOBENEWSWIRE
Quoin Pharma Q1 2024 Results And Corporate Update
09 May 2024 //
GLOBENEWSWIRE
Quoin Pharma Q1 2024 Results On May 9
02 May 2024 //
GLOBENEWSWIRE
Quoin Pharmaceuticals Announces Fourth Quarter and 2023 Financial Results
13 Mar 2024 //
GLOBENEWSWIRE
Quoin Pharmaceuticals Announces Fourth Quarter and 2023 Financial Results
07 Mar 2024 //
GLOBENEWSWIRE
Quoin Pharmaceuticals Announces Pricing of $6.5 Million Public Offering
05 Mar 2024 //
GLOBENEWSWIRE
Quoin Announces FDA Clearance of Clinical Optimization Plan for QRX003
13 Dec 2023 //
GLOBENEWSWIRE
Quoin Pharmaceuticals Announces Third Quarter 2023 Financial Results
08 Nov 2023 //
GLOBENEWSWIRE
Quoin Pharmaceuticals Announces Third Quarter 2023 Financial Results
03 Nov 2023 //
GLOBENEWSWIRE
Quoin Provides Corporate Update and Announces Q2 2023 Financial Results
02 Aug 2023 //
GLOBENEWSWIRE
Quoin Pharmaceuticals Announces Second Quarter 2023 Financial Results
27 Jul 2023 //
GLOBENEWSWIRE
Quoin Pharmaceuticals Provides Corporate Update and Announces 1Q 2023 FYR
08 May 2023 //
GLOBENEWSWIRE
Quoin Pharmaceuticals Announces 1Q 2023 FYR and Corporate Update Conference Call
02 May 2023 //
GLOBENEWSWIRE
Quoin Pharmaceuticals Announces 2022 Corporate Update Conference Call
02 Mar 2023 //
GLOBENEWSWIRE
Quoin Pharmaceuticals Announces Pricing of $7.0 Million Public Offering
22 Feb 2023 //
GLOBENEWSWIRE
Quoin Announces Dosing of First Patient in Trial in Netherton Syndrome
13 Dec 2022 //
GLOBENEWSWIRE
Quoin Announces Updated Timing of Q3 2022 Corporate Update Conference
03 Nov 2022 //
GLOBENEWSWIRE
Quoin Pharmaceuticals to Report 3Q 2022 FYR and Provide Corporate Update on Nov
01 Nov 2022 //
GLOBENEWSWIRE
Quoin Announces Plans to Initiate a Second Trial in Netherton Syndrome Patients
18 Oct 2022 //
GLOBENEWSWIRE
Quoin Establishes Patient Specific Website for Ongoing Netherton Syndrome
13 Sep 2022 //
GLOBENEWSWIRE
Quoin Pharmaceuticals Announces Second Quarter 2022 Financial Results
18 Aug 2022 //
GLOBENEWSWIRE
Quoin Pharmaceuticals to Report Q2 2022 Result and Provide Corporate Update
11 Aug 2022 //
GLOBENEWSWIRE
Quoin Pharmaceuticals Announces Closing of $16.8 Million Public Offering
09 Aug 2022 //
GLOBENEWSWIRE
Quoin Pharmaceuticals Announces Pricing of $16.8 Million Upsized Public Offering
05 Aug 2022 //
GLOBENEWSWIRE
Quoin Pharma Announces Receipt of Constructive Advice from EMA for QRX003
28 Jul 2022 //
GLOBENEWSWIRE
Endo Announces Agreement for Quoin Pharmaceuticals` QRX003 in Canada
15 Jul 2022 //
PRNEWSWIRE
Quoin Pharma Opens First Clinical Site for Netherton Syndrome Study
06 Jul 2022 //
GLOBENEWSWIRE
Quoin Pharma Announces Agreement with Leading Rare Disease Co.
15 Jun 2022 //
GLOBENEWSWIRE
Quoin Pharma Receives Nasdaq Deficiency Notice
15 Jun 2022 //
GLOBENEWSWIRE
Quoin Pharma Enters Exclusive Research Agreement for Scleroderma
23 May 2022 //
GLOBENEWSWIRE
Sienna says March Dividend
15 Mar 2022 //
GLOBENEWSWIRE
Quoin Pharma Submits Scientific Advice Briefing Document to EMA for QRX003
10 Mar 2022 //
GLOBENEWSWIRE
Quoin Pharma Extends Exclusive Distribution Agreement with ER-Kim for QRX003
01 Mar 2022 //
GLOBENEWSWIRE
Quoin Pharma Signs Exclusive Distribution Agreement with Neopharm for QRX003
17 Feb 2022 //
GLOBENEWSWIRE
Quoin Pharma Signs Exclusive Distribution Agreement with ER-Kim for QRX003
10 Feb 2022 //
GLOBENEWSWIRE
